GLI is overexpression in several human cancers, indicating that targeting GLI could be an attractive therapeutic strategy against human cancers (Desch et al. 2010; Pan et al. 2012b; Stecca and Ruiz 2010). The gene discussed is GLI1; the disease is cancer.